by The global Colonoscopy Bowel Preparation Drugs Market is estimated to be valued at US$ 2098.52 Mn in 2023 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview: Colonoscopy bowel preparation drugs are oral solutions administered before colonoscopy procedures to cleanse the bowel by causing diarrhea. This helps physicians get a clear view of the colon and intestine during the procedure. Bowel cleansing is necessary for accurate screening and diagnosis of colon-related diseases.
Market key trends: One of the key trends in the market is the rising adoption of PEG-based bowel cleansing solutions. PEG or polyethylene glycol is increasingly being used in colon cleansing drugs due to its superior cleansing efficacy and tolerability as compared to traditional lavage solutions. PEG works by drawing water into the intestine from surrounding tissues to produce semisolid stool that is easy to evacuate. It provides adequate cleansing for colonoscopies while also having less adverse effects like dehydration and electrolyte imbalances.
Segment Analysis
The global Colonoscopy Bowel Preparation Drugs Market Growth is segmented on the basis of product, form, end user, and region. By product, the polyethylene glycol segment is expected to dominate the market over the forecast period. Polyethylene glycol is the most commonly used product for colonoscopy bowel preparation due to its effectiveness in bowel cleansing and good tolerability. It causes minimal side effects such as dehydration and bloating as compared to other bowel cleansing products.
Key Takeaways
The global colonoscopy bowel preparation drugs market is expected to witness high growth, exhibiting CAGR of 4.9% over the forecast period, due to increasing prevalence of colorectal cancer and rising demand for elective colonoscopies.
Regional analysis
North America is expected to dominate the global colonoscopy bowel preparation drugs market over the forecast period. Higher awareness regarding colorectal cancer screening programs and availability of colonoscopy procedures drive the market in the region. Asia Pacific is anticipated to witness the fastest growth owing to increasing healthcare expenditure and presence of untapped opportunities in emerging countries such as China and India.
Key players
Key players operating in the colonoscopy bowel preparation drugs market are Ferring B.V., Bayer AG, Braintree, Bausch Health Companies Inc., and Norgine B.V. Ferring B.V. and Bausch Health Companies Inc. collectively hold over half of the market share owing to their diverse product portfolio and strong global presence.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
